Timmerman Philip, Luedtke Silke, van Amsterdam Peter, Brudny-Kloeppel Margarete, Lausecker Berthold, Fischmann Stephanie, Globig Susanne, Sennbro Carl-Johan, Jansat Josep M, Mulder Hans, Thomas Elizabeth, Knutsson Magnus, Kasel Dirk, White Stephen A, Kall Morten Anders, Mokrzycki-Issartel Nathalie, Freisleben Achim, Romero Fernando, Andersen Michael Pilgård, Knebel Norbert, de Zwart Marcel, Laakso Sirpa, Hucker Richard S, Schmidt Dietmar, Gordon Ben, Abbott Richard, Boulanger Pierre
Johnson & Johnson, Turnhoutseweg 30, B-2340 Beerse, Belgium.
Bioanalysis. 2009 Sep;1(6):1049-56. doi: 10.4155/bio.09.108.
Following intensive discussions, review, alignment of procedures and multiple surveys among their member companies, the European Bioanalysis Forum (EBF) is providing a recommendation on how to integrate incurred sample reproducibility (ISR) in the bioanalytical process. The recommendation aims to provide guidance throughout the lifecycle of a validated method, including the application of the method in study support. In its recommendation, the EBF considers both the internal discussions with EBF member companies, as well as the input provided in international meetings where ISR was discussed. The ultimate goal of the EBF recommendation is to ensure that bioanalytical methods can provide accurate and reproducible concentration data for pharmacokinetic and/or toxicokinetic evaluation, without any compromise, while safeguarding the optimal use of laboratory resources.
经过深入讨论、审查、程序调整以及在其成员公司间进行的多次调查后,欧洲生物分析论坛(EBF)就如何在生物分析过程中整合实测样品重现性(ISR)提出了一项建议。该建议旨在为经过验证的方法的整个生命周期提供指导,包括该方法在研究支持中的应用。在其建议中,EBF既考虑了与EBF成员公司的内部讨论,也考虑了在讨论ISR的国际会议上提供的意见。EBF建议的最终目标是确保生物分析方法能够为药代动力学和/或毒代动力学评估提供准确且可重现的浓度数据,不打任何折扣,同时保障实验室资源的优化利用。